Cypress Capital Group Acquires Shares of 5,539 Omega Healthcare Investors, Inc. (NYSE:OHI)

Cypress Capital Group purchased a new position in Omega Healthcare Investors, Inc. (NYSE:OHI) in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 5,539 shares of the real estate investment trust’s stock, valued at approximately $225,000.

Several other institutional investors also recently modified their holdings of the business. Advisors Asset Management Inc. increased its stake in shares of Omega Healthcare Investors by 2.6% during the third quarter. Advisors Asset Management Inc. now owns 118,273 shares of the real estate investment trust’s stock valued at $4,814,000 after purchasing an additional 3,041 shares in the last quarter. Pathstone Holdings LLC raised its stake in Omega Healthcare Investors by 23.9% during the third quarter. Pathstone Holdings LLC now owns 32,112 shares of the real estate investment trust’s stock valued at $1,307,000 after buying an additional 6,199 shares during the last quarter. Quest Partners LLC bought a new stake in Omega Healthcare Investors in the third quarter worth $514,000. Thrivent Financial for Lutherans grew its stake in shares of Omega Healthcare Investors by 1.5% in the third quarter. Thrivent Financial for Lutherans now owns 60,575 shares of the real estate investment trust’s stock worth $2,465,000 after acquiring an additional 871 shares during the last quarter. Finally, GoalVest Advisory LLC increased its holdings in shares of Omega Healthcare Investors by 3.0% during the third quarter. GoalVest Advisory LLC now owns 34,214 shares of the real estate investment trust’s stock valued at $1,393,000 after acquiring an additional 993 shares in the last quarter. 65.25% of the stock is currently owned by institutional investors.

Omega Healthcare Investors Stock Performance

NYSE OHI opened at $40.17 on Friday. The business’s 50 day moving average price is $40.64 and its 200-day moving average price is $36.88. Omega Healthcare Investors, Inc. has a fifty-two week low of $27.53 and a fifty-two week high of $44.42. The company has a market cap of $10.84 billion, a P/E ratio of 29.53, a P/E/G ratio of 1.25 and a beta of 0.99. The company has a debt-to-equity ratio of 1.10, a quick ratio of 6.48 and a current ratio of 6.48.

Omega Healthcare Investors Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Monday, November 4th were issued a $0.67 dividend. The ex-dividend date was Monday, November 4th. This represents a $2.68 annualized dividend and a dividend yield of 6.67%. Omega Healthcare Investors’s payout ratio is 197.06%.

Wall Street Analyst Weigh In

OHI has been the subject of a number of analyst reports. Royal Bank of Canada raised their price objective on shares of Omega Healthcare Investors from $39.00 to $43.00 and gave the company a “sector perform” rating in a research note on Monday, November 11th. Mizuho lowered shares of Omega Healthcare Investors from an “outperform” rating to a “neutral” rating and boosted their price objective for the stock from $34.00 to $35.00 in a report on Thursday, July 25th. Scotiabank increased their target price on Omega Healthcare Investors from $33.00 to $39.00 and gave the company a “sector perform” rating in a research note on Monday, August 26th. BNP Paribas upgraded Omega Healthcare Investors from a “neutral” rating to an “outperform” rating and set a $49.00 price target for the company in a research note on Thursday, October 31st. Finally, Berenberg Bank began coverage on Omega Healthcare Investors in a research report on Friday, October 18th. They set a “buy” rating and a $45.00 price objective on the stock. Seven investment analysts have rated the stock with a hold rating and five have issued a buy rating to the company. According to data from MarketBeat.com, Omega Healthcare Investors presently has a consensus rating of “Hold” and an average target price of $40.00.

Insiders Place Their Bets

In related news, CFO Robert O. Stephenson sold 22,542 shares of Omega Healthcare Investors stock in a transaction dated Friday, September 27th. The stock was sold at an average price of $40.19, for a total value of $905,962.98. Following the completion of the sale, the chief financial officer now directly owns 183,076 shares in the company, valued at $7,357,824.44. The trade was a 10.96 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, COO Daniel J. Booth sold 56,725 shares of the company’s stock in a transaction dated Friday, September 27th. The stock was sold at an average price of $40.25, for a total transaction of $2,283,181.25. Following the completion of the sale, the chief operating officer now directly owns 100,000 shares of the company’s stock, valued at approximately $4,025,000. This trade represents a 36.19 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.37% of the company’s stock.

Omega Healthcare Investors Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.